Keybank National Association Abb Vie Inc. Transaction History

Keybank National Association

$23.9 Billion
Q1 2024

A detailed history of Keybank National Association transactions in Abb Vie Inc. stock. As of the latest transaction made, Keybank National Association holds 849,242 shares of ABBV stock, worth $139 Million. This represents 0.65% of its overall portfolio holdings.

Number of Shares

849,242

Previous 849,251 0.0%

Holding current value

$139 Million

Previous $132 Million 17.51%

% of portfolio

0.65%

Previous 0.59%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$159.82 - $182.1 $1,438 - $1,638	-9 Reduced -0.0%	849,242 $155 Million
Q4 2023 Feb 13, 2024	SELL	$137.6 - $154.97 $686,486 - $773,145	-4,989 Reduced 0.58%	849,251 $132 Million
Q3 2023 Nov 08, 2023	SELL	$133.59 - $154.65 $1.93 Million - $2.23 Million	-14,412 Reduced 1.66%	854,240 $127 Million
Q2 2023 Aug 01, 2023	SELL	$132.51 - $164.9 $1.59 Million - $1.98 Million	-12,025 Reduced 1.37%	868,652 $117 Million
Q1 2023 May 10, 2023	SELL	$144.61 - $166.54 $4.47 Million - $5.14 Million	-30,890 Reduced 3.39%	880,677 $140 Million

Q4 2022 Jan 31, 2023	SELL	$138.31 - $165.87 $1.09 Million - $1.31 Million	-7,897 Reduced 0.86%	911,567 $147 Million
Q3 2022 Oct 27, 2022	SELL	$134.21 - $153.93 $124,681 - $143,000	-929 Reduced 0.1%	919,464 $123 Million
Q2 2022 Aug 08, 2022	SELL	$137.62 - $174.96 $2.1 Million - $2.66 Million	-15,226 Reduced 1.63%	920,393 $141 Million
Q1 2022 Apr 28, 2022	SELL	$131.98 - $163.75 $3.25 Million - $4.04 Million	-24,643 Reduced 2.57%	935,619 $152 Million
Q4 2021 Feb 07, 2022	SELL	$107.43 - $135.93 $810,989 - $1.03 Million	-7,549 Reduced 0.78%	960,262 $130 Million
Q3 2021 Nov 08, 2021	SELL	$106.4 - $120.78 $508,698 - $577,449	-4,781 Reduced 0.49%	967,811 $104 Million
Q2 2021 Aug 12, 2021	SELL	$105.21 - $117.21 $1.92 Million - $2.14 Million	-18,284 Reduced 1.85%	972,592 $110 Million
Q1 2021 May 07, 2021	SELL	$102.3 - $112.62 $1.41 Million - $1.56 Million	-13,829 Reduced 1.38%	990,876 $107 Million
Q4 2020 Feb 09, 2021	SELL	$80.49 - $108.67 $1.6 Million - $2.16 Million	-19,843 Reduced 1.94%	1,004,705 $108 Million
Q3 2020 Oct 29, 2020	SELL	$85.91 - $100.83 $919,151 - $1.08 Million	-10,699 Reduced 1.03%	1,024,548 $89.7 Million
Q2 2020 Aug 10, 2020	SELL	$73.37 - $98.18 $737,515 - $986,905	-10,052 Reduced 0.96%	1,035,247 $102 Million
Q1 2020 May 13, 2020	SELL	$64.5 - $97.79 $1.58 Million - $2.39 Million	-24,437 Reduced 2.28%	1,045,299 $79.6 Million
Q4 2019 Feb 05, 2020	SELL	$72.13 - $90.25 $899,316 - $1.13 Million	-12,468 Reduced 1.15%	1,069,736 $94.7 Million
Q3 2019 Nov 04, 2019	SELL	$62.98 - $75.72 $3.94 Million - $4.74 Million	-62,582 Reduced 5.47%	1,082,204 $81.9 Million
Q2 2019 Aug 01, 2019	SELL	$65.7 - $83.98 $2.22 Million - $2.84 Million	-33,816 Reduced 2.87%	1,144,786 $83.2 Million
Q1 2019 May 08, 2019	SELL	$77.14 - $90.79 $5.4 Million - $6.36 Million	-70,010 Reduced 5.61%	1,178,602 $95 Million
Q4 2018 Jan 30, 2019	SELL	$77.85 - $96.01 $2.45 Million - $3.02 Million	-31,468 Reduced 2.46%	1,248,612 $115 Million
Q3 2018 Nov 08, 2018	SELL	$88.91 - $98.84 $976,765 - $1.09 Million	-10,986 Reduced 0.85%	1,280,080 $121 Million
Q2 2018 Aug 08, 2018	SELL	$89.78 - $106.23 $634,565 - $750,833	-7,068 Reduced 0.54%	1,291,066 $120 Million
Q1 2018 May 15, 2018	SELL	$92.01 - $123.21 $1.31 Million - $1.75 Million	-14,234 Reduced 1.08%	1,298,134 $123 Million
Q4 2017 Feb 08, 2018	SELL	$89.56 - $98.21 $2.98 Million - $3.26 Million	-33,232 Reduced 2.47%	1,312,368 $127 Million
Q3 2017 Nov 02, 2017	SELL	$69.85 - $89.22 $309,854 - $395,779	-4,436 Reduced 0.33%	1,345,600 $120 Million
Q2 2017 May 14, 2018	SELL	N/A	-2,560 Reduced 0.19%	1,350,036 $97.9 Million
Q1 2017 May 14, 2018	SELL	N/A	-10,388 Reduced 0.76%	1,352,596 $88.1 Million
Q4 2016 May 14, 2018	BUY	N/A	1,362,984	1,362,984 $85.4 Million

Others Institutions Holding ABBV

# of Institutions

3,653

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $290B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Keybank National Association, based on Form 13F filings with the SEC.

News

Stay updated on Keybank National Association with notifications on news.

Account

Keybank National Association Abb Vie Inc. Transaction History